FDA Inspection 1061383 — Porton Biopharma Limited
The FDA completed an inspection of Porton Biopharma Limited on August 1, 2018 in Salisbury. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 1, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Salisbury (United Kingdom)